Picture of Tetra Bio Pharma logo

TBP — Tetra Bio Pharma News Story

0.000.00%
ca flag iconLast trade - 00:00
HealthcareSpeculativeMicro Cap

Brief: Tetra Bio Pharma- FDA says Co's Caumz Kit Can Be Evaluated As Combination Drug/Device Product

Oct 3 (Reuters) - Tetra Bio Pharma Inc  TBP.V :
    * TETRA BIO-PHARMA PROVIDES REGULATORY UPDATE FOR ITS
CAUMZ(TM)
KIT
    * TETRA BIO PHARMA INC - FDA HAS DETERMINED THAT COMPANY'S
CAUMZ
KIT CAN BE EVALUATED AS A COMBINATION DRUG/DEVICE PRODUCT
    * TETRA BIO PHARMA INC - CAUMZ KIT HAS BEEN ASSIGNED TO
CENTER FOR
DRUG EVALUATION AND RESEARCH FOR PREMARKET REVIEW

Source text for Eikon:  ID:nGNX8G8CgW 
Further company coverage:  TBP.V 

 (Reporting by Trisha Roy)
 ((Trisha.Roy@thomsonreuters.com;))

Recent news on Tetra Bio Pharma

See all news